Document is current
Any future updates will be listed below
-
Authors
Kamal, Muntasir https://orcid.org/0000-0002-5354-5747
Knox, Jessica https://orcid.org/0000-0003-1465-5852
Horne, Robert I. https://orcid.org/0000-0003-1534-2639
Tiwari, Om Shanker
Burns, Andrew R. https://orcid.org/0000-0002-8966-1280
Han, Duhyun
Levy, Davide https://orcid.org/0000-0002-8018-4836
Laor Bar-Yosef, Dana
Gazit, Ehud
Vendruscolo, Michele https://orcid.org/0000-0002-3616-1610
Roy, Peter J. https://orcid.org/0000-0003-2959-2276
-
Funding
Funding for this research was provided by:
John Templeton Foundation
Canadian Research Chairs program.
- License Information
-
More Information
Article History
Received: 14 December 2023
Accepted: 6 September 2024
First Online: 27 September 2024
Competing interests
: R.I.H. is a consultant of WaveBreak Therapeutics (formerly Wren Therapeutics). M.V. is a founder of WaveBreak Therapeutics. The remaining authors declare no competing interests.
